Newsletter
Pamrevlumab for IPF, Dapagliflozin in Critical Illness, Payer Involvement in Evidence Generation, and more

JAMA Editor’s Summary

Pamrevlumab for IPF, Dapagliflozin in Critical Illness, Payer Involvement in Evidence Generation, and more

Editor’s Summary by Mary McGrae McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the , issue.
August 6, 2024
ADVERTISEMENT

Pamrevlumab for IPF, Dapagliflozin in Critical Illness, Payer Involvement in Evidence Generation, and more

Editor’s Summary by Mary McGrae McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the August 6, 2024, issue.

ADVERTISEMENT
ADVERTISEMENT
Rethinking Alzheimer's Disease Podcast - Listen on Health Podcast Network

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

Buffer LinkedIn WhatsApp